$7.7M sweet spot round size
Most of their 41 investments are in rounds between $4M and $24M
2010
Mironid® Limited raised $38M on September 13, 2023
Investors: Sofinnova Partners, BGV (BioGeneration Ventures), Scottish Enterprise, University of Strathclyde and Epidarex Capital
Theolytics raised $28M on August 25, 2023
Investors: University of Oxford, M Ventures, Oxford Sciences Innovation and Epidarex Capital
Nyra Medical raised $20M on November 18, 2022
Investors: Georgia Research Alliance, Broadview Ventures Inc, Vensana Capital and Epidarex Capital
RapidPulse raised $11M on August 31, 2022
Investors: Syntheon, Broadview Ventures Inc, - and Epidarex Capital
Transine Therapeutics raised $5.8M on May 31, 2022
Investors: The Dementia Discovery Fund and Epidarex Capital
Kynos Therapeutics Ltd. raised $8.5M on April 7, 2022
Investors: Scottish Enterprise, IP Group plc and Epidarex Capital
Epsilogen Ltd raised $41M on March 2, 2022
Investors: 3B Future Health Fund, British Patient Capital, Schroders Capital, ALSA Ventures and Epidarex Capital
Undisclosed raised $24M on November 2, 2021
Investors: BGV (BioGeneration Ventures) and Epidarex Capital
LEUCID BIO raised $16M on October 21, 2021
Investors: 2invest financial, Sofinnova Partners, British Business Bank, Vulpes Investment Management and Epidarex Capital
Macomics raised $5.9M on July 29, 2021
Investors: Scottish Enterprise and Epidarex Capital